- Home
- INMB vs PLUR Comparison
INMB vs PLUR Comparison
Compare INMB & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- PLUR
- Stock Information
- Founded
- INMB 2015
- PLUR 2001
- Country
- INMB United States
- PLUR Israel
- Employees
- INMB N/A
- PLUR N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INMB Health Care
- PLUR Health Care
- Exchange
- INMB Nasdaq
- PLUR Nasdaq
- Market Cap
- INMB 53.4M
- PLUR 44.7M
- IPO Year
- INMB 2019
- PLUR N/A
- Fundamental
- Price
- INMB $1.91
- PLUR $4.70
- Analyst Decision
- INMB Buy
- PLUR Strong Buy
- Analyst Count
- INMB 4
- PLUR 1
- Target Price
- INMB $9.53
- PLUR $12.00
- AVG Volume (30 Days)
- INMB 822.2K
- PLUR 11.7K
- Earning Date
- INMB 10-30-2025
- PLUR 11-11-2025
- Dividend Yield
- INMB N/A
- PLUR N/A
- EPS Growth
- INMB N/A
- PLUR N/A
- EPS
- INMB N/A
- PLUR N/A
- Revenue
- INMB $50,000.00
- PLUR $1,034,000.00
- Revenue This Year
- INMB $142.83
- PLUR $395.40
- Revenue Next Year
- INMB $14,780.90
- PLUR $186.32
- P/E Ratio
- INMB N/A
- PLUR N/A
- Revenue Growth
- INMB N/A
- PLUR 203.23
- 52 Week Low
- INMB $1.71
- PLUR $3.33
- 52 Week High
- INMB $11.64
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- INMB 38.01
- PLUR 45.12
- Support Level
- INMB $1.71
- PLUR $4.33
- Resistance Level
- INMB $2.12
- PLUR $4.96
- Average True Range (ATR)
- INMB 0.12
- PLUR 0.27
- MACD
- INMB 0.04
- PLUR -0.02
- Stochastic Oscillator
- INMB 45.45
- PLUR 38.14
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.